ADAR1 Capital Management, LLC - Apr 24, 2025 SCHEDULE 13D/A Report for Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS)

Filing Manager
ADAR1 Capital Management, LLC
Reporting Manager
ADAR1 Capital Management, LLC
Security
Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
KROS
Shares outstanding
40.6M shares
Disclosed Ownership
5.39M shares
Ownership
13.3%
Form type
SCHEDULE 13D/A
Date filed
4/28/2025, 06:43 PM
Date of event
Apr 24, 2025
Previous filing
Apr 11, 2025
Next filing
May 8, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ADAR1 Capital Management, LLC 13.29% 5.39M 5.39M 0 /s/ Daniel Schneeberger Daniel Schneeberger, Manager 0001940272
ADAR1 Capital Management GP, LLC 11.46% 4.65M 4.65M 0 /s/ Daniel Schneeberger Daniel Schneeberger, Manager
Daniel Schneeberger 13.29% 5.39M 5.39M 0 /s/ Daniel Schneeberger Daniel Schneeberger